Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 Sep 23 424B4 Prospectus supplement with pricing info
- 31 Aug 23 EFFECT Notice of effectiveness
- 25 Aug 23 POS AM Prospectus update (post-effective amendment)
- 30 Aug 22 424B4 Prospectus supplement with pricing info
- 29 Aug 22 EFFECT Notice of effectiveness
- 22 Aug 22 F-1/A Registration statement (foreign) (amended)
-
7 Jul 22 F-1 Registration statement (foreign)
EVAX similar filings
- 30 Jan 24 Registration statement (foreign) (amended)
- 12 Jan 24 Registration statement (foreign)
- 22 Aug 22 Registration statement (foreign) (amended)
- 7 Jul 22 Registration statement (foreign)
- 3 Nov 21 Registration statement (foreign) (amended)
- 26 Oct 21 Registration statement (foreign)
- 1 Feb 21 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form F-1) and related Prospectus of Evaxion Biotech A/S for the registration of its ordinary shares and to the incorporation by reference therein of our report dated March 31, 2022, with respect to the consolidated financial statements of Evaxion Biotech A/S included in its Annual Report (Form 20-F) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ EY Godkendt Revisionspartnerselskab
Copenhagen, Denmark
July 7, 2022